News blog
Promising sequencing contender Oxford Nanopore and market leader Illumina sever financial ties
Two closely watched genetic sequencing technology firms who had been unhappily affiliated have now divorced. UK-based Oxford Nanopore announced on 15 November that it has raised £56.4 million – mostly by selling the 13.5% of its shares that had been owned by San Diego-based Illumina since 2009.
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells